// App-Quantinova.ai

4913 : Engineering dendritic cell-based vaccines as targeted immunotherapy against medulloblastoma, neuroblastoma, and Ewing sarcoma

Researchers

Presenter

  • Stacey Zahler

Principal Investigators

  • Wen Luo

  • Janet Ayello

  • Mitchell S. Cairo

Medical Centers

  • New York Medical College, Valhalla, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Medulloblastoma

  • Ewing's sarcoma

  • Neuroblastoma

  • Solid malignancies

  • Sarcoma

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Protein Arginine Methyltransferase 1

  • Human Leukocyte Antigen – DR isotype

  • Human leukocyte antigen A2

  • Translocator protein

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved